Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Solid Biosciences Inc. (SLDB) had Stock-Based Compensation of $16.91M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-49.79M |
|
-- |
|
-- |
|
$49.40M |
|
$-49.40M |
|
$-0.38M |
|
$-49.79M |
|
$-49.79M |
|
$-49.79M |
|
$-49.79M |
|
$-49.79M |
|
$-49.79M |
|
$-49.40M |
|
$-49.68M |
|
87.50M |
|
87.50M |
|
$-0.50 |
|
$-0.50 |
|
| Balance Sheet Financials | |
$205.46M |
|
$4.17M |
|
$27.08M |
|
$232.54M |
|
$33.47M |
|
-- |
|
$19.06M |
|
$52.53M |
|
$180.01M |
|
$180.01M |
|
$180.01M |
|
78.97M |
|
| Cash Flow Statement Financials | |
$-156.29M |
|
$-58.45M |
|
$194.45M |
|
$82.19M |
|
$61.89M |
|
$-20.30M |
|
|
Stock-Based Compensation |
$16.91M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.14 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-157.36M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-27.66% |
|
-27.66% |
|
-21.41% |
|
-27.66% |
|
$2.28 |
|
$-1.80 |
|
$-1.79 |
|